A pilot study was designed to estimate the variance components in the determination of the MIC of cefoxitin for isolates of the Bacteroides fragilis group. Twenty different organisms were tested, and replicate, trial, and reader variabilities were examined. When the total-variance component was used, if the true MIC was 16 ,ug/ml, then the chance that the observed MIC was between 8 and 32 ,ug/ml, inclusive, was 95%. For all analyses, the isolate (P = 0.0001) and reader (P < 0.03) effects were significant. The probability of specific MIC observations for various true MICs (over the range of 16 to 32 ,ug/ml at 4-,ug/ml increments) was calculated. For true MICs of 20, 24, and 28 ,ug/ml (1, 6, 7) . The procedures themselves are considered accurate to within + 1 twofold dilution, i.e., if the MIC for the quality control strain is within 1 twofold dilution of the quality control value, the study run is acceptable. Clustering of MICs about the breakpoint for certain antimicrobial agents has been seen in our laboratory and described by our group (7). In studies completed in our laboratory, we found that the MICs for 50 to 60% of all anaerobes (70% of the B. fragilis group) were within 1 twofold dilution of the breakpoint for cefoperazone, cefotaxime, ceftizoxime, cefoxitin, and penicillin G while 38% (46% of the B. fragilis group) were within 1 dilution for clindamycin (5, 6).
Bacteroides fragilis group strains are the anaerobes most frequently isolated from clinical infections and are among those most resistant to antimicrobial agents. In vitro susceptibility testing may provide valuable information about activities of certain agents and trends of anaerobic resistance patterns, but variation in testing methods among laboratories has led to a great deal of confusion regarding the reported resistance of Bacteroides species to various antimicrobial agents (1, 6, 7) . The procedures themselves are considered accurate to within + 1 twofold dilution, i.e., if the MIC for the quality control strain is within 1 twofold dilution of the quality control value, the study run is acceptable. Clustering of MICs about the breakpoint for certain antimicrobial agents has been seen in our laboratory and described by our group (7) . In studies completed in our laboratory, we found that the MICs for 50 to 60% of all anaerobes (70% of the B. fragilis group) were within 1 twofold dilution of the breakpoint for cefoperazone, cefotaxime, ceftizoxime, cefoxitin, and penicillin G while 38% (46% of the B. fragilis group) were within 1 dilution for clindamycin (5, 6 by using the test option on the random statement from the type II sum of squares within SAS PROC GLM (3).
RESULTS
The MICs are displayed in Table 1 . Some data from trial 1 were not reported and were excluded from analysis (because of technical problems in medium preparation); all other data were used in the analysis.
The results of separate analyses are presented in Table 2 . Table 3 summarizes the results for all 20 isolates obtained by using the mean value over the replicates. For all four analyses, the isolate effects were significant (P = 0.0001). There was also a significant reader effect (P< 0.03 for all four analyses); reader E always read the MIC at levels equal to or higher than those of reader D.
For isolates 1 to 5, the test (P = 0.0001) and reader (P = 0.0001) effects were highly significant, while the replicate effect (P = 0.80), the replicate nested in isolate effect (P = 0.08), and the test times replicate nested in isolate effect (P = 0.10) were not significant. In other words, the replicate effect, specimen division error, and test-to-test handling error were not significant. The total of the variance components was 0.3847, with an error component of 0.1572 (Table  2) . Thus, when the total-variance component was used if the true MIC was 16 jig/ml, then the probability that the observed MIC was 32 ,ug/ml was 44.6%, the probability that the observed MIC was 16 ,ug/ml was 44.6%, and the probability that the observed MIC was 8 p.g/ml was 5.3%. For isolates 6 to 10, the test effect (P = 0.0008), reader effect (P = 0.0025), the replicate nested in isolate effect (P = 0.04), and the test times replicate nested in isolate effect (P = 0.008) were all significant, while the replicate effect (P VOL. 34, 1990 on August 14, 2017 by guest http://aac.asm.org/ Downloaded from ANTIMICROB. AGENTS CHEMOTHER. = 0.49) was not significant. The total of the variance components was 0.3144, with an error component of 0.1344 (Table 2) . Thus, when the total-variance component was used, if the true MIC was 16 ,ug/ml, then the probability that the observed MIC was 32 jig/ml was 46.3%, for an observed MIC of 16 p.g/ml it was 46.3%, and the probability that it would be 8 ,ug/ml was 3.7%.
For isolates 11 to 20, the test effect (P = 0.003) and the reader effect (P = 0.03) were significant. The total of the variance components was 0.4688, with an error component of 0.3591 (Table 2) . Thus, when the total variance component was used, if the true MIC was 16 ,ug/ml, then the probability that the observed MIC would be 16 or 32 ,ug/ml was 42.8%, with the same upward bias.
The replicate effect was not significant for either of the two sets of isolates. Working with the mean for each set of replicates, we pooled the data for all 20 isolates. The test (P = 0.0001) and reader (P = 0.0001) effects were significant. The total of the variance components was 0.3666, with an error component of 0.2327 (Table 3) . Thus, when the totalvariance component was used, if the true MIC was 16 p.g/ml then the chance that the observed MIC would be between 8 and 32 ,ug/ml, inclusive, was 95%. Table 4 displays the probability of specific MIC observations for true MICs over the range of 16 to 32 ,ug/ml at 4-,ug/ml increments under the assumption of a standard deviation of 0.605 (as obtained from the total-variance component in Table 3 ). For a true MIC of 24 ,g/ml, the probability of reading 8 ,g/ml was 0.5%, that of reading 16 ,ug/ml was 15.6%, that of reading 32 ,ug/ml was 59.1%, that of reading 64 ,ug/ml was 23.8%, and that of reading 128 ,ug/ml was 1.0%. This illustrates that the chance of reading 16 or 32 ,g/ml was 74.7%. For a true MIC of 28 ,ug/ml, this probability dropped to 62.0%, with a 35.4% probability of reading the MIC as 64 ,ug/ml. For a true MIC of 20 ,ug/ml, this probability rose to 85.5% and the probabil- ity of being more than one dilution away was 14.5%. Clearly, an upward bias exists, in addition to sources of sizeable variation.
DISCUSSION The net effect of this analysis is that an MIC determination is subject to a rounding bias, as well as to significant sources of variation, such as test (day) and reader effects. Specimen handling and test-to-test variations introduce significant errors. The results of this study indicate significant potential for error in any MIC studies in which quotas are based on observed MICs as criteria for selection of an isolate for inclusion in the study. For example, if a study were required to have 100 isolates for which the MIC is at least 32 ,ug/ml for a given antibiotic, then selection of 100 organisms for which the observed MIC is 32 jxg/ml would include 5 isolates for which the MICs are 16 Kg/ml or lower.
The extent of the upward bias may be estimated in this type of study and corrected if desired. In this study, the correction factor (0.7, reciprocal of the square root of 2) was determined by simulating possible MIC distributions for various true MICs. This type of correction could be used to amend mean MICs; i.e., if the mean MIC were reduced by 30%, the bias would be corrected. Another approach would recognize that when one establishes a breakpoint of 32 ,ug/ml, for example, the actual cutoff point measured for a sample population is about 30% less, or -22 ,u.g/ml. (This fact might be of some use in trying to correlate clinical outcomes with susceptibility results, for example.) However, for MICs measured for clinical isolates, or even for percent susceptibility for sample populations, this correction factor would not be useful.
One common assumption was dispelled by this analysis. Generally, when we speak of a + 1 twofold dilution error, the The importance of an accurate, generally agreed upon, and easily understandable definition of the endpoint is underscored by this study. In this study, both readers were experienced technicians who had worked in the area of susceptibility testing extensively; both knew that they were involved in a study designed to estimate sources of variability. Nevertheless, there was a consistent discrepancy in their endpoint readings. Other organisms (e.g., Fusobacterium spp.) may introduce even greater variability because of the difficulties in endpoint determination (2) . Extensive training of technicians involved in susceptibility testing and frequent periodic surveillance of their technique are essential.
The trend (and, at times, editorial pressure) for reporting only MICs for 50 or 90% of the strains tested is disturbing in light of these considerations. The combination of the uncertain actual MICs as described in this study and the clustering effect of MICs about breakpoint concentrations that occurs with many beta-lactam agents, clindamycin, and chloramphenicol may result in a large but insignificant gap between the cumulative percent susceptibility at one concentration and the value at ±+1 twofold dilution greater (or less). For example, in the current study, in trial 3, with a breakpoint of 32 ,ug/ml, isolate 2 would be described as either susceptible or resistant, depending on which replicate was referred to, even with a single reader. Thus, we recommend that workers report the percent susceptibility at a reasonable range of values about the breakpoint (e.g., a range of 3 twofold dilutions). Narrowing the increments tested around the critical breakpoint concentrations or using a system that can measure exact MICs (i.e., narrowing the error factor) would also alleviate some of the uncertainty inherent in this technique.
